WELL Health Technologies Corp T.WELL

Laurentian Bank Notes

[retiredcf]

Finally, on the telehealth market within the tech sector, Agostino (Laurentian Bank) said expanding multiples for a number of names earlier on in the pandemic also led to contraction later on.

“While companies such as WELL Health, CloudMD and Dialogue have all delivered meaningful growth (including +ten per cent organic growth), we believe investor fatigue and an overcrowded marketplace overshadow solid company performances. In our view, consolidation may be a theme that plays out in 2022 to build end-to- end market leaders. We highlight CloudMD’s proposed acquisition of MindBeacon as an example. We focus investors to Savaria for a company with steady profitable growth, solid fundaments (aging population), and a rising dividend as a means for healthcare exposure,” he said.

[monty613]

agreed. WELL is nicely positioned with cash reserves, ample senior debt financing credit lines (ie. cheap credit), and positive FCF. they are in a position to make a monster acquisition, or be the subject of one themself. GLTA

[HotDiggityDogg]

Monty there has been absolutely zero news from WELL on anything. Meanwhile stock has been tanking. Wouldn't it make sense for Company to try to do something to help the shareholders when they are losing so much ? First it was a short attack, then tax loss selling, then macro Fed stuff, but the main concern for me is lack of buyers. If there was buyers, shorts wouldn't be in control. Even

[monty613]

despite BudFox's assertions, the stock wasn't really in a serious downtrend until November when it tanked along with the rest of the telehealth sector (and broader market). there was zero company specific news that drove this. companies don't comment on short term movements in their share price. at all. they did comment in November about the Virtual Services division and they provided

[Capharnaum]

Fluff news release and management statements rarely ever do anything good for a stock price. What matters are the financial results. If they can build on Q3 2021, then the stock will move back higher than its current price. Will it move back all the way to $9? Maybe not. I think we're seeing selling pressure from those that bought between $6-8 just based on the charts (overall company